Albany, NY -- (SBWIRE) -- 06/08/2018 -- The global market discussion of guillain-barre syndrome can be found in the latest study publicized to the vast archive of Market Research Hub (MRH). The study is titled as "Guillain-Barré Syndrome Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025", which offers a holistic outlook of the market covering market trends, factors along with industry growth prospects from 2012 to 2017, and forecast to 2025. The report also highlights market prospects at the global and regional level. Prime regions emphasized in the study are North America, Europe, Asia Pacific, Middle East & Africa (MEA), and South America; these are analyzed in terms of market revenue.
Request For Sample Report: https://www.marketresearchhub.com/enquiry.php?type=S&repid=1781417
Guillain-Barre syndrome or GBS is a severe inflammatory disorder of the peripheral nerves. It is a rare disease. Rare diseases cause a significant financial and medical burden on patients, healthcare systems, and medical fraternity. According to the Centers for Disease Control & Prevention (CDC), the geriatric population is at a higher risk of developing Guillain-Barre syndrome (GBS), as the incidence of the syndrome increases with age. Considering this fact, analysts have identified that the market for guillain-barre is expanding at a moderate pace.
Research Findings
According to the research prime findings, the global Guillain–Barré syndrome market, which was valued at US$ 454.0 Mn in 2016 and is projected to register a CAGR of over 5% from 2017 to 2025 to reach value of US$ 708.6 Mn by 2025. The report also suggests that the rising rate of this syndrome diagnosis in developing countries is likely to drive the Guillain–Barré syndrome market throughout the mentioned forecast period.
On the basis of geographical expansion, the research finds that market in North America is projected to witness steady growth, driven by factors such as highly structured healthcare industry and convenience of well-defined reimbursement policies for rare diseases from private and public health insurance companies. Besides, the market in APAC estimated to display significant growth opportunities.
Browse Full Report with TOC- https://www.marketresearchhub.com/report/guillainbarr-syndrome-market-global-industry-analysis-size-share-growth-trends-and-forecast-2017-2025-report.html
Furthermore, the research broadly classified that market on the basis of therapeutics, distribution channel and route of administration. In terms of therapeutics, the market for Guillain-Barre syndrome has been segmented broadly into intravenous immunoglobulin, plasma exchange, and others (analgesics, anticonvulsants, LMWH, etc.). Based on route of administration, the market has been segmented into oral and parenteral.
As the incidences of gullain-barre syndrome are growing, the need for treatment of Guillain-Barre syndrome by off-label use of intravenous immunoglobulins is increasing. This factor is expected to drive the market during the forecast period. The use of intravenous immunoglobulins is beneficial over plasma exchange, therefore IVIG segment is expected to expand at a significant rate till 2025.
In the end, the research study highlights key players operating in the global Guillain–Barré syndrome market. They are Grifols S.A., Shire plc, China Biologic Products Holdings, Inc., Octapharma AG, Nihon Pharmaceutical Co., Ltd., CSL Behring LLC, Akari Therapeutics, PLC, Biotest AG, and Kedrion s.p.A.
Enquire about this Report- https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1781417
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH's expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
Contact Us
90 State Street,
Albany, NY 12207,
United States
Toll Free : 800-998-4852 (US-Canada)
Email : press@marketresearchhub.com
Website : https://www.marketresearchhub.com/
Read Industry News at - https://www.industrynewsanalysis.com/